Evidence map›Paper›PMID 36551778›Full record

ArticleBiomedicines2022

Changes in Alprazolam Metabolism by CYP3A43 Mutants.

Jie Zhao, Sijie Liu, Clemens Alexander Wolf, Gerhard Wolber, Maria Kristina Parr, Matthias Bureik

Abstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie ZhaoSchool of Pharmaceutical Science and Technology, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.ORCID 0000-0002-0776-9563
Sijie LiuPharmaceutical and Medicinal Chemistry (Computer-Aided Drug Design), Institute of Pharmacy, Freie Universitaet Berlin, Koenigin-Luise-Strasse 2+4, 14195 Berlin, Germany.ORCID 0000-0001-8834-3881
Clemens Alexander WolfPharmaceutical and Medicinal Chemistry (Computer-Aided Drug Design), Institute of Pharmacy, Freie Universitaet Berlin, Koenigin-Luise-Strasse 2+4, 14195 Berlin, Germany.ORCID 0000-0002-5682-1815
Gerhard WolberPharmaceutical and Medicinal Chemistry (Computer-Aided Drug Design), Institute of Pharmacy, Freie Universitaet Berlin, Koenigin-Luise-Strasse 2+4, 14195 Berlin, Germany.ORCID 0000-0002-5344-0048
Maria Kristina ParrPharmaceutical and Medicinal Chemistry (Pharmaceutical Analysis), Institute of Pharmacy, Freie Universitaet Berlin, Koenigin-Luise-Strasse 2+4, 14195 Berlin, Germany.ORCID 0000-0001-7407-8300
Matthias BureikSchool of Pharmaceutical Science and Technology, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.ORCID 0000-0002-9515-6248

Funding

German Academic Exchange Service noneTianjin University Independent Innovation Fund none
6 · The paper itself

Abstract

Alprazolam is a triazolobenzodiazepine which is most commonly used in the short-term management of anxiety disorders, often in combination with antipsychotics. The four human members of the CYP3A subfamily are mainly responsible for its metabolism, which yields the main metabolites 4-hydroxyalprazolam and α-hydroxyalprazolam. We performed a comparison of alprazolam metabolism by all four CYP3A enzymes upon recombinant expression in the fission yeast

Indexed as

alprazolamCYP3A43 mutantsCYP3A enzymesdrug metabolismSchizosaccharomyces pombe

Identifiers

PMID36551778
PMCPMC9775082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.